NCT06076837 2026-01-12The Seven Trial: Exploiting the Unfolded Protein ResponseHonorHealth Research InstitutePhase 1 Active not recruiting6 enrolled
NCT04041050 2025-02-14A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmAbbViePhase 1 Active not recruiting85 enrolled